Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Suspended 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Dermatologic 4Gastrointestinal 2Other hematologic neoplasm 1Genitourinary 1

Conditions

Stomach Neoplasms 1Bile Duct Neoplasms 1

Interventions

Gemcitabine 218Fluorouracil 142Oxaliplatin 132Capecitabine 122pembrolizumab 113Irinotecan 110Leucovorin 104Bevacizumab 98Nivolumab 80Cisplatin 80130-nm albumin-bound paclitaxel 80Cetuximab 79Radiotherapy 78Albumin-Bound Paclitaxel 59Sorafenib 56Paclitaxel 53Cyclophosphamide 50Carboplatin 47Magnetic Resonance Spectroscopy 44Specimen Handling 39Docetaxel 37Taxes 36fludarabine 34Radiation 34durvalumab 33Ipilimumab 33Erlotinib Hydrochloride 33Biopsy 33Radiosurgery 27Folfox protocol 27

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × Protein Subunit Vaccines × Gastrointestinal × Clear all
NCT00624182 2015-06-23

Gemcitabine With Peptide Vaccine Therapy in Treating Patients With Bile Duct Cancer

Akita University Hospital

Phase 1 Suspended
9 enrolled
Gastrointestinal

Bile Duct Neoplasms

NCT00845611 2012-04-06

Human Leukocyte Antigen (HLA) - A*2402 Restricted Peptide Vaccine Therapy in Patients With Advanced Gastric Cancer

Kinki University

Phase 1 Completed
9 enrolled
Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡